ID EU-7 AC CVCL_8865 SY 91-17; Emory University-7 DR BioSample; SAMN03151619 DR cancercelllines; CVCL_8865 DR IARC_TP53; 3827 DR Wikidata; Q54832867 RX PubMed=7630190; RX PubMed=7888679; RX PubMed=9108419; RX PubMed=9823951; RX PubMed=12592342; RX PubMed=20143388; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00198. CC Population: Caucasian. CC Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line). CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. CC Cell type: T-cell; CL=CL_0000084. DI NCIt; C7953; Childhood T acute lymphoblastic leukemia DI ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0207 ! CCRF-CEM SX Female AG 3Y11M CA Cancer cell line DT Created: 06-06-12; Last updated: 10-04-25; Version: 30 // RX PubMed=9108419; DOI=10.1182/blood.V89.8.2986; RA Findley, Harry W. Jr. RA Gu, Lu-Bing RA Yeager, Andrew M. RA Zhou, Mu-Xiang RT "Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with RT p53 status and sensitivity to apoptosis in childhood acute RT lymphoblastic leukemia."; RL Blood 89:2986-2993(1997). // RX PubMed=20143388; DOI=10.1002/ijc.25242; RA Capes-Davis, Amanda RA Theodosopoulos, George RA Atkin, Isobel RA Drexler, Hans Gunther RA Kohara, Arihiro RA MacLeod, Roderick A.F. RA Masters, John R.W. RA Nakamura, Yukio RA Reid, Yvonne A. RA Reddel, Roger Robert RA Freshney, Robert Ian RT "Check your cultures! A list of cross-contaminated or misidentified RT cell lines."; RL Int. J. Cancer 127:1-8(2010). // RX PubMed=12592342; DOI=10.1038/sj.leu.2402799; RA Drexler, Hans Gunther RA Dirks, Wilhelm Gerhard RA Matsuo, Yoshinobu RA MacLeod, Roderick A.F. RT "False leukemia-lymphoma cell lines: an update on over 500 cell RT lines."; RL Leukemia 17:416-426(2003). // RX PubMed=7630190; RA Zhou, Mu-Xiang RA Gu, Lu-Bing RA James, Charles David RA He, Ju RA Yeager, Andrew M. RA Smith, Stephen D. RA Findley, Harry W. Jr. RT "Homozygous deletions of the CDKN2 (MTS1/p16ink4) gene in cell lines RT established from children with acute lymphoblastic leukemia."; RL Leukemia 9:1159-1161(1995). // RX PubMed=7888679; DOI=10.1182/blood.V85.6.1608.bloodjournal8561608; RA Zhou, Mu-Xiang RA Yeager, Andrew M. RA Smith, Stephen D. RA Findley, Harry W. Jr. RT "Overexpression of the MDM2 gene by childhood acute lymphoblastic RT leukemia cells expressing the wild-type p53 gene."; RL Blood 85:1608-1614(1995). // RX PubMed=9823951; DOI=10.1038/sj.leu.2401198; RA Zhou, Mu-Xiang RA Gu, Lu-Bing RA Yeager, Andrew M. RA Findley, Harry W. Jr. RT "Sensitivity to Fas-mediated apoptosis in pediatric acute RT lymphoblastic leukemia is associated with a mutant p53 phenotype and RT absence of Bcl-2 expression."; RL Leukemia 12:1756-1763(1998). //